For those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is
now enrolling.
The HEAL-IST Trial will evaluate the safety & effectiveness of a hybrid sinus node-sparing ablation procedure. Learn more: <a href="https://t.co/GctEkS7k6a" target="_blank">https://t.co/GctEkS7k6a</a>